awmsg logo



clevidipine (Cleviprex®)


Reference No. 384

Publication date:
01/05/2012


Appraisal information

clevidipine (Cleviprex®) 0.5 mg/ml emulsion for injection


Company: The Medicines Company
BNF category: Cardiovascular system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 25/04/2012

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, clevidipine (Cleviprex®) cannot be endorsed for use within NHS Wales for rapid reduction of blood pressure in the perioperative setting.
Statement of Advice (SOA)
Download